Search - tctmd.com

Displaying 161 - 180 of 8957

Sort: Relevancy | Date

Presentation TCT 2025

Commentary

Presenter: Tsuyoshi Kaneko

October 27, 2025

Presentation TCT 2025

Non-Inferiority Trials – Bridge or Barrier to Patient-Centered Progress?

Presenter: Sanjay Kaul

October 27, 2025

Presentation TCT 2025

Tendyne Transcatheter Mitral Valve System in Patients with Severe Mitral Annular Calcification: One-year Outcomes from the SUMMIT Severe MAC Cohort

Presenter: Paul Sorajja

October 27, 2025

Presentation TCT 2025

Subgroup Analyses in Non-Inferiority Studies: Signal or Noise?

Presenter: Björn Redfors

October 27, 2025

Presentation TCT 2025

Commentary

Presenter: Stefan Blankenberg

October 27, 2025

Presentation TCT 2025

How to Interpret a “Negative” Non-Inferiority Trial: Case-Based Discussion

Presenter: Donald Cutlip

October 27, 2025

Presentation TCT 2025

Long-Term Follow-up of the PARTNER 3 Low-Risk Randomized Trial: Seven-Year Clinical and Echocardiographic Outcomes

Presenter: Michael J. Mack

October 27, 2025

Presentation TCT 2025

Sequential Superiority After Non-Inferiority: Opportunities and Risks

Presenter: Roseann M. White

October 27, 2025

Presentation TCT 2025

Commentary

Presenter: Bernard Prendergast

October 27, 2025

Presentation TCT 2025

How to Design (and How Not to Design) a Non-Inferiority Trial

Presenter: Kevin Bainey

October 27, 2025

Presentation TCT 2025

Defining the Prevalence of Valvular Heart Disease in Older Americans: The PREVUE-VALVE Study

Presenter: David J. Cohen

October 27, 2025

Presentation TCT 2025

Real-World Data from Data Aggregators: Opportunities and Challenges

Presenter: Ryan Ahern

October 27, 2025

Presentation TCT 2025

TCT 759: Use of Amiodarone for Prevention of New-Onset Atrial Fibrillation after Transcatheter Aortic Valve Replacement: PAF-TAVR Randomized Clinical Trial

Presenter: Gabriela Tirado-Conte

October 27, 2025

Presentation TCT 2025

Hybrid Trial Designs and Real-World Evidence: Will They Ever Be Prime Time?

Presenter: Robert W. Yeh

October 27, 2025

Presentation TCT 2025

Rational Dispersion of Novel Technologies & the Need for Additional Evidence Generation: Lessons Learned from Recent CMS NCDs

Presenter: Sreekanth Vemulapalli

October 27, 2025

Presentation TCT 2025

Linkage of Clinical Trial Evidence with Administrative Claims: Pros and Cons

Presenter: Eric A. Secemsky

October 27, 2025

Presentation TCT 2025

Swimming with the SHARCs: Advancing Harmonization of Definitions Used in Clinical Trials of Cardiogenic Shock

Presenter: Mitchell W. Krucoff

October 27, 2025

Presentation TCT 2025

Enhancing Cardiovascular Device Clinical Trial Efficiency: Opportunities for Bayesian Predictive Modeling

Presenter: Ben Saville

October 27, 2025

News Conference News TCT 2025

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

Michael O'Riordan

October 26, 2025

News Conference News TCT 2025

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

Yael L. Maxwell

October 26, 2025

Advertisement

Commentary

Non-Inferiority Trials – Bridge or Barrier to Patient-Centered Progress?

Tendyne Transcatheter Mitral Valve System in Patients with Severe Mitral Annular Calcification: One-year Outcomes from the SUMMIT Severe MAC Cohort

Subgroup Analyses in Non-Inferiority Studies: Signal or Noise?

Commentary

How to Interpret a “Negative” Non-Inferiority Trial: Case-Based Discussion

Long-Term Follow-up of the PARTNER 3 Low-Risk Randomized Trial: Seven-Year Clinical and Echocardiographic Outcomes

Sequential Superiority After Non-Inferiority: Opportunities and Risks

Commentary

How to Design (and How Not to Design) a Non-Inferiority Trial

Defining the Prevalence of Valvular Heart Disease in Older Americans: The PREVUE-VALVE Study

Real-World Data from Data Aggregators: Opportunities and Challenges

TCT 759: Use of Amiodarone for Prevention of New-Onset Atrial Fibrillation after Transcatheter Aortic Valve Replacement: PAF-TAVR Randomized Clinical Trial

Hybrid Trial Designs and Real-World Evidence: Will They Ever Be Prime Time?

Rational Dispersion of Novel Technologies & the Need for Additional Evidence Generation: Lessons Learned from Recent CMS NCDs

Linkage of Clinical Trial Evidence with Administrative Claims: Pros and Cons

Swimming with the SHARCs: Advancing Harmonization of Definitions Used in Clinical Trials of Cardiogenic Shock

Enhancing Cardiovascular Device Clinical Trial Efficiency: Opportunities for Bayesian Predictive Modeling

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content